Rafael De La Torre
Program Director, Neurosciences Program; Professor at Universitat Pompeu Fabra / Hospital del Mar Research Institute
Data updated
Research Footprint
Rafael De La Torre appears in 8 tracked papers (2006–2023), most studied alongside MDMA, 2C-X and Ayahuasca, across Healthy Volunteers, Depressive Disorders and Medicinal Chemistry & Drug Development.
Most-cited paper: Pharmacology of MDMA in humans (178 citations).
Frequent co-authors: Rafael Torre, Magí Farré and Johannes Ramaekers.
Background & Research
Rafael de la Torre Fornell is a Spanish clinical pharmacologist and neurosciences researcher based at the Hospital del Mar Research Institute (IMIM) and Universitat Pompeu Fabra. His research has focused on the clinical pharmacology of abused drugs, especially MDMA/ecstasy, and later expanded to related psychopharmacology and metabolomics studies involving compounds such as ayahuasca and 2C-B. He has held leadership roles in neurosciences research at IMIM and has been associated with the Toxicology/medicine faculty at UPF.
Key Impact
A leading clinical pharmacologist in Spain whose human studies helped define the effects, pharmacokinetics, and safety of MDMA and other psychoactive substances, including work relevant to psychedelic and entactogenic research.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Rafael De La Torre is associated with.